about
Emerging technologies for studying DNA methylation for the molecular diagnosis of cancerS1PR1-STAT3 signaling is crucial for myeloid cell colonization at future metastatic sites.Molecular lymphatic mapping of the sentinel lymph nodeMolecular clonality of in-transit melanoma metastasis.CCL21 chemokine regulates chemokine receptor CCR7 bearing malignant melanoma cells.Proteomic profiling of primary breast cancer predicts axillary lymph node metastasis.LC/MS-based quantitative proteomic analysis of paraffin-embedded archival melanomas reveals potential proteomic biomarkers associated with metastasis.Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy.Serial monitoring of circulating melanoma cells during neoadjuvant biochemotherapy for stage III melanoma: outcome prediction in a multicenter trialAssociation of circulating tumor cells with serum tumor-related methylated DNA in peripheral blood of melanoma patientsMultimarker quantitative real-time PCR detection of circulating melanoma cells in peripheral blood: relation to disease stage in melanoma patientsLINE-1 hypomethylation during primary colon cancer progressionDevelopment of sporadic microsatellite instability in colorectal tumors involves hypermethylation at methylated-in-tumor loci in adenomaAcetylated STAT3 is crucial for methylation of tumor-suppressor gene promoters and inhibition by resveratrol results in demethylation.DNA methylation and gene deletion analysis of brain metastases in melanoma patients identifies mutually exclusive molecular alterationsEpigenetic inactivation of ID4 in colorectal carcinomas correlates with poor differentiation and unfavorable prognosis.Synthesis of universal unmethylated control DNA by nested whole genome amplification with phi29 DNA polymerase.Endosialin Expression in Metastatic Melanoma Tumor Microenvironment Vasculature: Potential Therapeutic Implications.Prediction of breast tumor progression by integrity of free circulating DNA in serum.Molecular upstaging based on paraffin-embedded sentinel lymph nodes: ten-year follow-up confirms prognostic utility in melanoma patientsCD8+ T-cell immunosurveillance constrains lymphoid premetastatic myeloid cell accumulationEpigenetic changes of EGFR have an important role in BRAF inhibitor-resistant cutaneous melanomasBrain metastasis is predetermined in early stages of cutaneous melanoma by CD44v6 expression through epigenetic regulation of the spliceosomeMulti-platform Genome-wide Analysis of Melanoma Progression to Brain Metastasis.RASAL2 activates RAC1 to promote triple-negative breast cancer progressionDNA methylation of apoptosis genes in rectal cancer predicts patient survival and tumor recurrence.MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1AA direct plasma assay of circulating microRNA-210 of hypoxia can identify early systemic metastasis recurrence in melanoma patientsAnalytical and Clinical Validation of a Digital Sequencing Panel for Quantitative, Highly Accurate Evaluation of Cell-Free Circulating Tumor DNAIn Situ Sodium Bisulfite Modification of Genomic DNA from Microdissected Melanoma Paraffin-Embedded Archival Tissues.Lentivirus-induced 'Smart' dendritic cells: Pharmacodynamics and GMP-compliant production for immunotherapy against TRP2-positive melanomaThe CASC15 Long Intergenic Noncoding RNA Locus Is Involved in Melanoma Progression and Phenotype SwitchingMolecular markers in malignant cutaneous melanoma: gift horse or one-trick pony?IRAK1 is a therapeutic target that drives breast cancer metastasis and resistance to paclitaxel.Molecular upstaging of sentinel lymph nodes in melanoma: where are we now?The prognostic value of circulating tumor cells in patients with melanoma: a systematic review and meta-analysis.Cytotoxic T lymphocytes that recognize decameric peptide sequences of retinoblastoma binding protein 1 (RBP-1) associated with human breast cancer.BCL2A1 is a lineage-specific antiapoptotic melanoma oncogene that confers resistance to BRAF inhibition.Estrogen receptor and HER2/neu status affect epigenetic differences of tumor-related genes in primary breast tumors.Prognostic molecular biomarkers for cutaneous malignant melanoma
P50
Q28087759-7B09E783-7877-4081-9EBC-F0529EE7CC4BQ30514214-4CD59409-FF17-46CB-80EB-0C45EC900A8AQ30860284-6B0F10F9-2617-4E2B-8309-49A3EE813102Q30985474-73C35A1C-A7FD-488E-BD27-F7346F033281Q33201297-BF6F2919-1E8D-48D0-B8F0-0F935B549309Q33267070-4A5F8F2E-4EDD-4D41-B68D-8CDE0403CB8FQ33409847-F9251480-6F7C-44D9-AFA2-F07FD2A57DB4Q33796956-C0538657-47AD-4BAE-AF41-C44A099BC62FQ33796997-D61C55ED-7B4A-4925-8C6F-92AD630E27D0Q33797039-F221CE2F-BB0B-4D22-A6EC-4CF98AEBD25EQ33797133-6A33DB19-6031-4791-8215-90A5F0C6BEAEQ33886421-4F923F93-C841-4E24-903D-F9A6E40DDB5EQ34254446-E09D0C2F-1D7B-43B2-ADC4-733DE229A3F5Q34272080-788F9051-2498-4ADC-9A73-1B43AA9DED53Q34359695-0162CA93-5760-48F1-8A6F-BD448B8FFD03Q34372077-2BAEA400-97D1-409C-8F4C-272B00341EEAQ34396042-406C4780-44CE-46D4-B1EC-14C1DFC40317Q34481202-B5BFAEC7-5562-44A3-BB54-DD8B0DA937D1Q34565015-C07A279E-2BA9-491C-9DD4-911660510812Q34614180-4D4786A1-0BA2-41AC-BBE0-0ADBCA969DA2Q34944413-15AE164A-4831-49F1-9BAD-CC0310AE43E8Q35018167-542D41F6-3BF3-4829-BBF7-2E4B11CB97E7Q35023463-2817948C-15DD-41B8-8F0A-A9A3CECDFB78Q35029567-CEA48778-1C04-4646-9A1D-0303E96C283DQ35145423-176F6042-8BC6-4D7D-93C2-4EB88773F4C8Q35184586-28026BB0-FC33-4A64-BB62-0DCDFB969121Q35550210-BEF69539-CC93-4F74-BEB1-619448D49F9DQ35740150-DC90E990-299F-465F-A298-FD8542A38A0DQ35810461-F56BE85B-FA71-4A23-A5F0-C7351604B959Q35867352-95B3BDCC-ABD3-4F62-9004-5D8074C81AB8Q36031874-DB45D121-189A-4FDB-83F0-AF124B51CD31Q36054438-58353F04-5A8D-4853-A048-612426B274CCQ36223186-80E717B5-DAE2-47EF-82AD-877ADC9B4637Q36266768-22A97061-2CFA-48B3-8E1B-FD2EE7976DD6Q36456887-E6609F36-8E36-4EC9-8A10-93496D50C6D6Q36561415-3D7E3429-30E8-448D-AA52-37861A766908Q36619554-1662D996-BD3B-4C60-8607-566CAFA40C75Q36692818-BED71489-4E37-425F-A6A1-77E14B7FD54DQ36787353-6097049F-EE3F-47F2-B372-BBAE94910DAAQ36905877-B7C31A64-18DA-4608-92B7-4ED11B5F8D9E
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Dave S. Hoon
@ast
Dave S. Hoon
@en
Dave S. Hoon
@es
Dave S. Hoon
@nl
Dave S. Hoon
@sl
type
label
Dave S. Hoon
@ast
Dave S. Hoon
@en
Dave S. Hoon
@es
Dave S. Hoon
@nl
Dave S. Hoon
@sl
prefLabel
Dave S. Hoon
@ast
Dave S. Hoon
@en
Dave S. Hoon
@es
Dave S. Hoon
@nl
Dave S. Hoon
@sl
P106
P1153
7006671900
P21
P31
P496
0000-0003-1915-3683